Search - tctmd.com

Displaying 121 - 140 of 373

$Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?$

Presentation THT 2023

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Presenter: Michael Sutherland

March 21, 2023

Presentation THT 2023

Cardiac Conditioning Induction by Paced Simulation of Exercise Heart Rate

Presenter: Michael Sauer

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

News Conference News ACC 2023

Studies Support (Careful) Return to Sport for Athletes With Genetic Conditions

Michael O'Riordan

March 07, 2023

News Daily News

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Michael O'Riordan

January 30, 2023

News Daily News

Less Than One in Five CVD Trials Led by Women

Michael O'Riordan

January 25, 2023

News Daily News

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Michael O'Riordan

January 17, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Conference News PCR London Valves 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Daily News

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

Michael O'Riordan

October 17, 2022

News Daily News

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Michael O'Riordan

October 05, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

Presentation TCT 2022

TCT 341: Intermittent Occlusion of the Superior Vena Cava Reduces Estimated Stressed Blood Volume in Patients with Acutely Decompensated Heart Failure

Presenter: Michael Kiernan

September 18, 2022

Advertisement

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Cardiac Conditioning Induction by Paced Simulation of Exercise Heart Rate

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Studies Support (Careful) Return to Sport for Athletes With Genetic Conditions

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Less Than One in Five CVD Trials Led by Women

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

The Biggest News of 2022: TCTMD’s Top 10

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Valve Fracture for ViV TAVI Linked With Higher Mortality

TCT 341: Intermittent Occlusion of the Superior Vena Cava Reduces Estimated Stressed Blood Volume in Patients with Acutely Decompensated Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content